Virtual Library

Start Your Search

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

Filter Results:

Show Only Available Presentations

  • +

    EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy

    • Type: E-Poster
    • Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
    • Presentations: 34
    • Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
    • +

      EP05.01-009 - A Clinical Outcome Comparison of IMRT and VMAT in Stage II and III NSCLC Irradiated with Radical Intent

      Author(s): Jose Belderbos

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      EP05.01-010 - External Validation of Two Prediction Models for Severe Radiation-induced Lymphopenia during Concurrent Chemoradiotherapy for Lung Cancer

      Author(s): Peter S.N. van Rossum

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA03 - Predicting Outcomes in Patients with Early Disease NSCLC

    • Type: Mini Oral
    • Track: Early Stage Non-small Cell Lung Cancer
    • Presentations: 14
    • Moderators:Terufumi Kato
    • Coordinates: 8/07/2022, 12:00 - 13:00, Hall C8
    • +

      MA03.09 - Real-World Acute Toxicity and 90-day Mortality in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy.

      12:37 - 12:42  |  Author(s): Peter S.N. van Rossum

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA06 - Impact of COVID-19 on Cancer Management and Protection from Vaccines

    • Type: Oral
    • Track: Management of Lung Cancer in the Era of COVID-19
    • Presentations: 11
    • +

      OA06.05 - Impact of COVID-19 Pandemic on Proportion and Treatment Patterns for Stage I Non-small Cell Lung Cancer in the Netherlands

      11:22 - 11:32  |  Author(s): Nienke Wolfhagen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ES23 - Optimizing Radio-Chemo-Immunotherapy for Locally Advanced NSCLC

    • Type: Education Session
    • Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
    • Presentations: 9
    • Moderators:Billy W Loo
    • Coordinates: 8/08/2022, 14:45 - 15:45, Hall C2
    • +

      ES23.01 - Session Introduction

      14:45 - 14:46  |  Author(s): Billy W Loo

      • Abstract

      Loading...

    • +

      ES23.02 - Session Introduction

      14:46 - 14:47  |  Author(s): Jose Belderbos

      • Abstract

      Loading...

    • +

      ES23.03 - Early Integration of Immune Checkpoint Inhibition into Radio-Chemotherapy

      14:47 - 14:59  |  Author(s): Willemijn S.M.E. Theelen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES23.04 - Management of Patients with Oncogenic Driver Mutations

      14:59 - 15:11  |  Author(s): Ross Soo

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES23.05 - Next-Generation Radiotherapy in the Era of Immunotherapy

      15:11 - 15:23  |  Author(s): Ken Harada

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES23.06 - Diagnosis and Management of Pneumonitis after Radio-Chemo-Immunotherapy

      15:23 - 15:35  |  Author(s): Alexander Louie

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES23.07 - Live Q&A

      15:35 - 15:45

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Session Moderator

      15:35 - 15:45  |  Author(s): Billy W Loo

      • Abstract

      Loading...

    • +

      Session Moderator

      15:35 - 15:45  |  Author(s): Jose Belderbos

      • Abstract

      Loading...